Advertisement
As of 10:45AM EST. Market open.
| Previous Close | 51.32 |
| Open | 51.67 |
| Bid | 51.87 x 100 |
| Ask | 52.38 x 100 |
| Day's Range | 51.49 - 52.31 |
| 52 Week Range | 42.75 - 64.47 |
| Volume | |
| Avg. Volume | 480,260 |
| Market Cap | 2.819B |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | 120.73 |
| EPS (TTM) | 0.43 |
| Earnings Date | Feb 19, 2025 - Feb 24, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 69.00 |
ZacksLivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint
LIVN's aura6000 significantly increases responder rates. The device also reduces AHI and ODI levels. A premarket approval application will be filed soon.
Business WireLivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences
LONDON, November 14, 2024--LivaNova PLC announced Vladimir Makatsaria, CEO, will present a general business update during fireside chats at Stifel, Wolfe and Piper in New York.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.